CA2606567A1 - Use of adamantyl methoxydiphenyl propenoic acid for the treatment of acne - Google Patents

Use of adamantyl methoxydiphenyl propenoic acid for the treatment of acne Download PDF

Info

Publication number
CA2606567A1
CA2606567A1 CA002606567A CA2606567A CA2606567A1 CA 2606567 A1 CA2606567 A1 CA 2606567A1 CA 002606567 A CA002606567 A CA 002606567A CA 2606567 A CA2606567 A CA 2606567A CA 2606567 A1 CA2606567 A1 CA 2606567A1
Authority
CA
Canada
Prior art keywords
acne
mice
treatment
comedones
lecithin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002606567A
Other languages
English (en)
French (fr)
Inventor
Claudio Pisano
Loredana Vesci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2606567A1 publication Critical patent/CA2606567A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
CA002606567A 2005-05-20 2006-05-05 Use of adamantyl methoxydiphenyl propenoic acid for the treatment of acne Abandoned CA2606567A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
ITRM2005A000248 2005-05-20
PCT/EP2006/062088 WO2006122883A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (1)

Publication Number Publication Date
CA2606567A1 true CA2606567A1 (en) 2006-11-23

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002606567A Abandoned CA2606567A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydiphenyl propenoic acid for the treatment of acne

Country Status (13)

Country Link
US (1) US7635719B2 (cg-RX-API-DMAC7.html)
EP (1) EP1890671B1 (cg-RX-API-DMAC7.html)
JP (1) JP5072833B2 (cg-RX-API-DMAC7.html)
KR (1) KR101307910B1 (cg-RX-API-DMAC7.html)
CN (1) CN101180028B (cg-RX-API-DMAC7.html)
AR (1) AR054361A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006248981B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611289A2 (cg-RX-API-DMAC7.html)
CA (1) CA2606567A1 (cg-RX-API-DMAC7.html)
IT (1) ITRM20050248A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007014222A (cg-RX-API-DMAC7.html)
TW (1) TWI365753B (cg-RX-API-DMAC7.html)
WO (1) WO2006122883A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンC(Ascorbicacid)を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
MXPA04008684A (es) * 2002-03-12 2004-12-06 Galderma Res & Dev Uso de adapaleno para tratamiento de trastornos dermatologicos.

Also Published As

Publication number Publication date
WO2006122883A9 (en) 2012-10-04
AR054361A1 (es) 2007-06-20
AU2006248981A1 (en) 2006-11-23
CN101180028A (zh) 2008-05-14
ITRM20050248A1 (it) 2006-11-21
KR20080016573A (ko) 2008-02-21
HK1117737A1 (en) 2009-01-23
EP1890671A1 (en) 2008-02-27
US7635719B2 (en) 2009-12-22
JP5072833B2 (ja) 2012-11-14
TW200716192A (en) 2007-05-01
EP1890671B1 (en) 2014-03-05
US20080153916A1 (en) 2008-06-26
MX2007014222A (es) 2008-02-07
CN101180028B (zh) 2010-12-08
TWI365753B (en) 2012-06-11
BRPI0611289A2 (pt) 2010-08-31
KR101307910B1 (ko) 2013-09-16
AU2006248981B2 (en) 2011-06-02
JP2008540603A (ja) 2008-11-20
WO2006122883A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
HK59493A (en) Dermatological, pharmaceutical or cosmetic composition consisting of hydrated lipid lamellar phases or liposomes and containing retinoids or analogues such as carotenoids
CN1255053A (zh) 抗坏血酸基-磷酰基-胆固醇
Vishwakarma et al. Emulgel: A novel technique for transdermal drug delivery
Runnsjö et al. A novel microparticle based formulation for topical delivery of FOL-005, a small peptide
HK1223297A1 (en) Topical retinoid solutions
Guleria et al. Decoding acne vulgaris: insights into pathogenesis, treatment modalities, diagnosis and recent advancements
AU2006248981B2 (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
RU2450836C1 (ru) Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
Aggnihotri Formulation and development of botanicals-based herbal serum
WO2019044670A1 (ja) ざ瘡様疾患を治療又は予防するための皮膚外用組成物
HK1117737B (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
Salim Emerging Formulations and Clinical Applications of Topical Salicylic Acid in Acne management
WO2021076722A1 (en) Compositions and methods of treating acne and photoaging
US10022348B2 (en) Topical solution of isotretinoin
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
Farah The effect of heat and chemical penetration enhancers on the follicular absorption of topically applied drugs
WO2021189077A1 (en) Methods for treating acne
White et al. Pharmacology of salicylic acid (SA) in acne vulgaris Otto Mills, PhD, Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Donald Adler, DO, private practice, Doylestown, PA, United States; Robert Verdicchio, PhD, Verdi Enterprise, Succasunna, NJ The role of SA is acne treatment is dependent upon several pharmacological actions
Consensus Topical retinoids
Grossman et al. The science of skin care

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20150505